keyword
https://read.qxmd.com/read/38585853/three-modes-of-viral-adaption-by-the-heart
#21
Cameron D Griffiths, Millie Shah, William Shao, Cheryl A Borgman, Kevin A Janes
Viruses elicit long-term adaptive responses in the tissues they infect. Understanding viral adaptions in humans is difficult in organs such as the heart, where primary infected material is not routinely collected. In search of asymptomatic infections with accompanying host adaptions, we mined for cardio-pathogenic viruses in the unaligned reads of nearly one thousand human hearts profiled by RNA sequencing. Among virus-positive cases (∼20%), we identified three robust adaptions in the host transcriptome related to inflammatory NFκB signaling and post-transcriptional regulation by the p38-MK2 pathway...
March 29, 2024: bioRxiv
https://read.qxmd.com/read/38584847/a-narrative-review-on-adverse-drug-reactions-of-covid-19-treatments-on-the-kidney
#22
REVIEW
Fatemeh Jahanshahi, Seyed Behnam Jazayeri, Mohammad Mirahmadi Eraghi, Leonardo Oliveira Reis, Mahtab Hamidikia, Shayan Amiri, Seyed Mohammad Kazem Aghamir
Studies showed that the respiratory is not the only system affected by coronavirus 2, while cardiovascular, digestive, and nervous systems, as well as essential organs such as the kidneys, can be affected by this virus. In this review, we have studied the epidemiology, clinical, and laboratory findings on COVID-19 infection renal involvement, mortality, physiopathology, remaining renal sequels after recovery, underlying renal disease, and renal injury due to its treatment. Also, protective measures for kidney injury are explained in three levels...
2024: Open Medicine (Warsaw, Poland)
https://read.qxmd.com/read/38580885/direct-acting-antiviral-therapy-for-patients-with-chronic-hepatitis-c-infection-and-decompensated-cirrhosis
#23
REVIEW
Brian L Pearlman
Patients with chronic hepatitis C virus (HCV) infection and decompensated cirrhosis are an important population for antiviral therapy yet under-represented in clinical trials. HCV direct-acting antiviral (DAA) therapies, unlike interferon-containing regimens, can be safely utilized in decompensated patients. Per guidelines from the American Association for the Study of Liver Diseases (AASLD), therapy of choice in HCV and decompensated cirrhosis is sofosbuvir, an HCV polymerase inhibitor, combined with a replication complex inhibitor (NS5A inhibitor) with or without ribavirin...
April 5, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38578354/patients-with-stat1-gain-of-function-mutations-display-increased-apoptosis-which-is-reversed-by-the-jak-inhibitor-ruxolitinib
#24
JOURNAL ARTICLE
Laura Dotta, Francesca Todaro, Manuela Baronio, Mauro Giacomelli, Marinella Pinelli, Martina Giambarda, Beatrice Brognoli, Silvia Greco, Francesca Rota, Manuela Cortesi, Annarosa Soresina, Daniele Moratto, Cesare Tomasi, Rosalba Monica Ferraro, Silvia Giliani, Raffaele Badolato
INTRODUCTION: The signal transducer and activator of transcription (STAT1) gain-of-function (GOF) syndrome accounts for most cases of chronic mucocutaneous candidiasis but is characterized by a broader clinical phenotype that may include bacterial, viral, or invasive fungal infections, autoimmunity, autoinflammatory manifestations, vascular complications, or malignancies. The severity of lymphopenia may vary and influence the infectious morbidity. METHODS: In our cohort of seven STAT1-GOF patients, we investigated the mechanisms that may determine T lymphopenia, we characterized the interferon gene signature (IGS) and analyzed the effect of ruxolitinib in reverting the immune dysregulation...
April 5, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38578122/occult-hepatitis-b-virus-infection-and-current-perspectives-on-global-who-2030-eradication
#25
REVIEW
Shanmugam Saravanan, Esaki M Shankar, Ramachandran Vignesh, Pitchaipillai Sankar Ganesh, Sathish Sankar, Vijayakumar Velu, Davey M Smith, Pachamuthu Balakrishnan, Dhivya Viswanathan, Rajakumar Govindasamy, Arcot R Venkateswaran
The current World Health Organization (WHO) Hepatitis Elimination Strategy suffers from lack of a target for diagnosing or expunging occult HBV infection. A sizable segment of the global population has an undetected HBV infection, particularly the high-risk populations and those residing in countries like India with intermediate endemicity. There is growing proof that people with hidden HBV infection can infect others, and that these infections are linked to serious chronic hepatic complications, especially hepatocellular carcinoma...
April 5, 2024: Journal of Viral Hepatitis
https://read.qxmd.com/read/38577490/the-effects-of-urolithin-a-on-poly-i-c-induced-microglial-activation
#26
JOURNAL ARTICLE
Yakum Benard Mingo, Lea Gabele, Niklas Lonnemann, Bert Brône, Martin Korte, Shirin Hosseini
Neuroinflammation can be triggered by various stimuli, including viral infections. Viruses can directly invade the brain and infect neuronal cells or indirectly trigger a "cytokine storm" in the periphery that eventually leads to microglial activation in the brain. While this initial activation of microglial cells is important for viral clearance, chronic activation leads to excessive inflammation and oxidative stress, which can be neurotoxic. Remarkebly, recent studies have shown that certain viruses such as influenza A virus, coronavirus, herpes virus and Epstein-Barr virus may be involved in the development of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis...
2024: Frontiers in Cellular Neuroscience
https://read.qxmd.com/read/38575708/the-wound-microbiota-microbial-mechanisms-of-impaired-wound-healing-and-infection
#27
REVIEW
Aayushi Uberoi, Amelia McCready-Vangi, Elizabeth A Grice
The skin barrier protects the human body from invasion by exogenous and pathogenic microorganisms. A breach in this barrier exposes the underlying tissue to microbial contamination, which can lead to infection, delayed healing, and further loss of tissue and organ integrity. Delayed wound healing and chronic wounds are associated with comorbidities, including diabetes, advanced age, immunosuppression and autoimmune disease. The wound microbiota can influence each stage of the multi-factorial repair process and influence the likelihood of an infection...
April 4, 2024: Nature Reviews. Microbiology
https://read.qxmd.com/read/38573196/lingering-effects-of-covid-19-in-the-care-of-perioperative-patients
#28
JOURNAL ARTICLE
Linjia Jia, Sagar Navare, Marguerite Hoyler
PURPOSE OF REVIEW: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can lead to organ dysfunction and clinical symptoms beyond the acute infection phase. These effects may have significant implications for the management of perioperative patients. The purpose of this article is to provide a systems-based approach to the subacute and chronic effects of SARS-CoV-2 that are most relevant to anesthesiology practice. RECENT FINDINGS: In 2024, COVID-19 remains a concern for anesthesiologists due ongoing new infections, evolving viral strains, and relatively low rates of booster vaccination in the general population...
March 11, 2024: Current Opinion in Anaesthesiology
https://read.qxmd.com/read/38571392/yf17d-based-vaccines-standing-on-the-shoulders-of-a-giant
#29
REVIEW
Lorena Sanchez-Felipe, Yeranddy A Alpizar, Ji Ma, Lotte Coelmont, Kai Dallmeier
Live-attenuated yellow fever vaccine (YF17D) was developed in the 1930s as the first ever empirically derived human vaccine. Ninety years later, it is still a benchmark for vaccines made today. YF17D triggers a particularly broad and polyfunctional response engaging multiple arms of innate, humoral and cellular immunity. This unique immunogenicity translates into an extraordinary vaccine efficacy and outstanding longevity of protection, possibly by single-dose immunization. More recently, progress in molecular virology and synthetic biology allowed engineering of YF17D as a powerful vector and promising platform for the development of novel recombinant live vaccines, including two licensed vaccines against Japanese encephalitis and dengue, even in paediatric use...
April 3, 2024: European Journal of Immunology
https://read.qxmd.com/read/38571295/reactivation-of-herpesvirus-type-6-and-iga-igm-mediated-responses-to-activin-a-underpin-long-covid-including-affective-symptoms-and-chronic-fatigue-syndrome
#30
JOURNAL ARTICLE
Aristo Vojdani, Abbas F Almulla, Bo Zhou, Hussein K Al-Hakeim, Michael Maes
BACKGROUND: Persistent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reactivation of dormant viruses, and immune-oxidative responses are involved in long COVID. OBJECTIVES: To investigate whether long COVID and depressive, anxiety, and chronic fatigue syndrome (CFS) symptoms are associated with IgA/IgM/IgG to SARS-CoV-2, human herpesvirus type 6 (HHV-6), Epstein-Barr Virus (EBV), and immune-oxidative biomarkers. METHODS: We examined 90 long COVID patients and ninety healthy controls...
April 4, 2024: Acta Neuropsychiatrica
https://read.qxmd.com/read/38569227/furanocoumarins-promote-proteasomal-degradation-of-viral-hbx-protein-and-down-regulate-cccdna-transcription-and-replication-of-hepatitis-b-virus
#31
JOURNAL ARTICLE
Purnima Tyagi, Ankita Singh, Jitendra Kumar, Belal Ahmad, Aparna Bahuguna, Perumal Vivekanandan, Shiv Kumar Sarin, Vijay Kumar
Nucleot(s)ide analogues, the current antiviral treatments against chronic hepatitis B (CHB) infection, are non-curative due to their inability to eliminate covalently closed circular DNA (cccDNA) from the infected hepatocytes. Preclinical studies have shown that coumarin derivatives can effectively reduce the HBV DNA replication. We evaluated the antiviral efficacy of thirty new coumarin derivatives in cell culture models for studying HBV. Furanocoumarins Fc-20 and Fc-31 suppressed the levels of pre-genomic RNA as well as cccDNA, and reduced the secretion of virions, HBsAg and HBeAg...
March 24, 2024: Virology
https://read.qxmd.com/read/38566493/metabolic-causes-of-liver-disease-among-adults-living-with-hiv-from-low-and-middle-income-countries-a-cross-sectional-study
#32
JOURNAL ARTICLE
Marie Kerbie Plaisy, Albert K Minga, Gilles Wandeler, Gad Murenzi, Niharika Samala, Jeremy Ross, Alvaro Lopez, Ephrem Mensah, Renée de Waal, Mark H Kuniholm, Lameck Diero, Sonali Salvi, Rodrigo Moreira, Alain Attia, Ardele Mandiriri, Fabienne Shumbusho, Suzanne Goodrich, Dhanushi Rupasinghe, Paola Alarcon, Fernanda Maruri, Hugo Perrazo, Antoine Jaquet
INTRODUCTION: Liver disease is a leading cause of morbidity and mortality among persons living with HIV (PLHIV). While chronic viral hepatitis has been extensively studied in low- and middle-income countries (LMICs), there is limited information about the burden of metabolic disorders on liver disease in PLHIV. METHODS: We conducted a cross-sectional analysis of baseline data collected between October 2020 and July 2022 from the IeDEA-Sentinel Research Network, a prospective cohort enrolling PLHIV ≥40 years on antiretroviral treatment (ART) for ≥6 months from eight clinics in Asia, Americas, and central, East, southern and West Africa...
April 2024: Journal of the International AIDS Society
https://read.qxmd.com/read/38566231/inefficient-antiviral-response-in-reconstituted-small-airway-epithelium-from-chronic-obstructive-pulmonary-disease-patients-following-human-parainfluenza-virus-type-3-infection
#33
JOURNAL ARTICLE
Louise Bondeelle, Maud Salmona, Véronique Houdouin, Elise Diaz, Jacques Dutrieux, Séverine Mercier-Delarue, Samuel Constant, Song Huang, Anne Bergeron, Jérôme LeGoff
Chronic obstructive pulmonary disease (COPD) affects over 250 million individuals globally and stands as the third leading cause of mortality. Respiratory viral infections serve as the primary drivers of acute exacerbations, hastening the decline in lung function and worsening the prognosis. Notably, Human Parainfluenza Virus type 3 (HPIV-3) is responsible for COPD exacerbations with a frequency comparable to that of Respiratory Syncytial Virus and Influenza viruses. However, the impact of HPIV-3 on respiratory epithelium within the context of COPD remains uncharacterized...
April 2, 2024: Virology Journal
https://read.qxmd.com/read/38566070/survey-of-lived-experiences-and-challenges-in-hepatitis-b-management-and-treatment
#34
JOURNAL ARTICLE
Catherine Freeland, Charles Adjei, Jack Wallace, Su Wang, Jessica Hicks, Danjuma Adda, Cary James, Chari Cohen
Almost 300 million people are living with chronic hepatitis B infection worldwide and most remain undiagnosed and at risk for liver cancer. In 2015 the World Health Organization (WHO) developed guidelines for the prevention, care, and treatment of persons with chronic hepatitis B and in early 2023 began to work on updating these guidelines. In March 2023, a self-administered, anonymous online survey was launched, aiming to identify patient preferences related to the clinical management of hepatitis B including current management, treatment, and care experiences, preferences regarding engagement with providers, and preferences related to simplifying hepatitis B care access...
April 2, 2024: BMC Public Health
https://read.qxmd.com/read/38565755/mir-3188-inhibits-hepatitis-b-virus-transcription-by-targeting-bcl-2
#35
JOURNAL ARTICLE
Shijie Wang, Ying Xie, Fufei Liu, Jianrong Wang, Yinghao Yang, Junxue Wang, Yongxiang Wang, Xiaofeng Hang
Transcription of the covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV) is subject to dual regulation by host factors and viral proteins. MicroRNAs (miRNAs) can regulate the expression of target genes at the post-transcriptional level. Systematic investigation of miRNA expression in HBV infection and the interaction between HBV and miRNAs may deepen our understanding of the transcription mechanisms of HBV cccDNA, thereby providing opportunities for intervention. miRNA sequencing and real-time quantitative PCR (qRT-PCR) were used to analyze miRNA expression after HBV infection of cultured cells...
April 2, 2024: Archives of Virology
https://read.qxmd.com/read/38563804/exploring-the-impact-of-different-inflammatory-cytokines-on-hepatitis-c-virus-infection
#36
JOURNAL ARTICLE
Noha G Bader El Din, Sally Farouk
Hepatitis C virus (HCV) infection is a global health concern affecting millions worldwide. Chronic HCV infection often leads to liver inflammation and can progress to cirrhosis and hepatocellular carcinoma. Inflammatory cytokines are crucial in modulating the immune response during HCV infection. This review aims to investigate the impact of different inflammatory cytokines on HCV infection and associated immune responses. This review was conducted to identify relevant studies on the interplay between inflammatory cytokines and HCV infection...
April 2, 2024: Journal of Interferon & Cytokine Research
https://read.qxmd.com/read/38562375/comparison-of-time-to-negative-conversion-of-sars-cov-2-between-young-and-elderly-among-asymptomatic-and-mild-covid-19-patients-a-cohort-study-from-a-national-containment-center
#37
JOURNAL ARTICLE
Imen Zemni, Cyrine Bennasrallah, Ines Charrada, Wafa Dhouib, Amani Maatouk, Donia Ben Hassine, Rim Klii, Meriem Kacem, Manel Ben Fredj, Hela Abroug, Salma Mhalla, Maha Mastouri, Chawki Loussaief, Ines Jlassi, Ines Bouanène, Asma Sriha Belguith
OBJECTIVE: We aimed to study the relationship between age and time to negative conversion of SARS-CoV-2 in patients with asymptomatic and mild forms of COVID-19. METHODS: We conducted a cohort study including all patients diagnosed with COVID-19 from the national COVID-19 containment center of Tunisia. Patients were subdivided into two cohorts: (under 60 years) and (over 60 years) and were followed up until PCR negativization. Log rank test and Cox regression were applied to compare time to negative conversion between the old group and the young group...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38562366/extrahepatic-manifestations-of-chronic-hepatitis-c-virus-hcv-infection
#38
Bella Garg, Amirmohsen Arbabi, Purnell A Kirkland
Hepatitis C virus (HCV) is a well-recognized, major cause of various liver-related conditions such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Apart from liver disease, chronic HCV infection is also associated with several extrahepatic manifestations that can lead to significant morbidity and mortality. These extrahepatic manifestations include essential mixed cryoglobulinemia (EMC), lymphomas, porphyria cutanea tarda, lichen planus, necrolytic acral erythema, glomerulonephritis, subclinical autoantibody formation, immune thrombocytopenia, thyroid disease, Sjögren's disease/sicca symptoms, diabetes mellitus, ocular diseases, musculoskeletal disorders, cardiovascular diseases, neurocognitive dysfunction, and leukocytoclastic vasculitis...
March 2024: Curēus
https://read.qxmd.com/read/38559200/cd39-is-expressed-on-functional-effector-and-tissue-resident-memory-cd8-t-cells
#39
Jordan F Isaacs, Hanna N Degefu, Tiffany Chen, Sierra A Kleist, Shawn C Musial, Myles A Ford, Tyler G Searles, Chun-Chieh Lin, Alexander G J Skorput, Keisuke Shirai, Mary Jo Turk, George J Zanazzi, Pamela C Rosato
The ecto-ATPase CD39 is expressed on exhausted CD8+ T cells in chronic viral infection and has been proposed as a marker of tumor-specific CD8+ T cells in cancer, but the role of CD39 in an effector and memory T cell response has not been clearly defined. We report that CD39 is expressed on antigen-specific CD8+ short-lived effector cells (SLECs), while it's co-ecto-enzyme, CD73, is found on memory precursor effector cells (MPEC) in vivo . Inhibition of CD39 enzymatic activity during in vitro T cell priming enhances MPEC differentiation in vivo after transfer and infection...
March 17, 2024: bioRxiv
https://read.qxmd.com/read/38558899/symptom-intensity-of-post-covid-and-long-covid-syndromes-in-patients-entering-rehabilitation-treatment
#40
JOURNAL ARTICLE
Jan Ceklarz
INTRODUCTION: The problem of post-COVID symptoms is still being analysed. Many of them may be related to other conditions, but the new appearance and greater intensity of some of them, e.g. fatigue, musculoskeletal pain, and neuropathic pain, seem to be related to a previous viral infection. Efforts are being made to determine in more detail the most characteristic symptoms of post-COVID syndrome. The conditions of rehabilitation after COVID-19 provide an opportunity for such observations...
2024: Reumatologia
keyword
keyword
19036
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.